Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pralatrexate

EU orphan designation number: EU/3/10/741   
Active ingredient: Pralatrexate
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Allos Therapeutics Limited
71 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire SG4 0TY, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/06/2010 Orphan Designation EMEA/OD/135/09 (2010)3912 of 10/06/2010
30/09/2010 Transfer of orphan designation EMEA/OD/135/09/T/01 (2010)6814 of 28/09/2010